Multivalent inhibition of the Aspergillus fumigatus KDNase

Mathieu Scalabrini1, Denis Loquet1, Camille Rochard2

  • 1Nantes Université, CNRS, CEISAM, UMR 6230, F-44000 Nantes, France. sebastien.gouin@univ-nantes.fr.

Insights

Researchers developed potent inhibitors for Aspergillus fumigatus KDNase (AfKDNAse) using a multivalent strategy. The poly-KDN compound significantly reduced fungal filamentation, showing promise as an antivirulence factor.

Area of Science:

  • Biochemistry
  • Mycology
  • Medicinal Chemistry

Background:

  • Aspergillus fumigatus is an opportunistic pathogen causing severe infections in immunocompromised individuals.
  • AfKDNAse, an exoglycosidase targeting the rare sugar KDN, is implicated in fungal cell wall structure and virulence.
  • Effective inhibitors are needed to study AfKDNAse function and develop new antifungal strategies.

Purpose of the Study:

  • To design and synthesize novel, enzymatically stable inhibitors of AfKDNAse.
  • To evaluate the inhibitory activity of KDN derivatives against recombinant AfKDNAse.
  • To assess the antivirulence potential of the most effective inhibitors against A. fumigatus.

Main Methods:

  • Design of C2, C9-linked heterodi-KDN and polymeric KDN compounds.
  • Synthesis of inhibitors using click chemistry for the polymeric compound.
  • Enzymatic inhibition assays using recombinant AfKDNAse.
  • Assessment of poly-KDN's effect on A. fumigatus filamentation.

Main Results:

  • Designed thio-KDN motifs for stable inhibitors.
  • Achieved moderate and strong inhibition with di-KDN and poly-KDN compounds, respectively.
  • Poly-KDN demonstrated over 900-fold improved inhibitory activity (IC50 = 1.52 ± 0.37 μM) compared to a monovalent KDN reference.
  • Poly-KDN significantly reduced A. fumigatus filamentation at micromolar concentrations.

Conclusions:

  • Multivalency is an effective strategy for developing potent KDNase inhibitors.
  • Poly-KDN represents the most potent synthetic KDNase inhibitor reported to date.
  • Poly-KDN exhibits antivirulence properties by inhibiting fungal filamentation, suggesting therapeutic potential.

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...